These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18853752)

  • 1. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line.
    Lee BK; Kim MJ; Jang HS; Lee HR; Ahn KM; Lee JH; Choung PH; Kim MJ
    In Vivo; 2008; 22(5):593-7. PubMed ID: 18853752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
    Erdem NF; Carlson ER; Gerard DA; Ichiki AT
    J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
    Tsai CH; Hsieh YS; Yang SF; Chou MY; Chang YC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):710-6. PubMed ID: 12789153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
    Riedel F; Götte K; Schwalb J; Hörmann K
    Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.
    Fiore E; Fusco C; Romero P; Stamenkovic I
    Oncogene; 2002 Aug; 21(34):5213-23. PubMed ID: 12149643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression.
    Chiang WC; Wong YK; Lin SC; Chang KW; Liu CJ
    Oral Dis; 2006 Jan; 12(1):27-33. PubMed ID: 16390465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells.
    Hayashido Y; Urabe K; Yoshioka Y; Kitano H; Okamoto T; Matsuya T
    Int J Oncol; 2003 Mar; 22(3):657-62. PubMed ID: 12579321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells.
    Ylipalosaari M; Thomas GJ; Nystrom M; Salhimi S; Marshall JF; Huotari V; Tervahartiala T; Sorsa T; Salo T
    Exp Cell Res; 2005 Oct; 309(2):273-83. PubMed ID: 16024014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro.
    Sundelin K; Roberg K; Grénman R; Håkansson L
    Acta Otolaryngol; 2005 Jul; 125(7):765-73. PubMed ID: 16012040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of NK cell activity in patients with oral maxillofacial squamous cell carcinoma].
    Wang JM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1989 Mar; 24(2):101-3, 128. PubMed ID: 2512074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.
    Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL
    Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
    Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
    Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma.
    Lin MH; Liu SY; Su HJ; Liu YC
    Oral Oncol; 2006 Oct; 42(9):907-13. PubMed ID: 16730219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X; Wei H; Wang H; Tian Z
    Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
    Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
    Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases expressed in squamous cell carcinoma of the oral cavity: correlation with clinicopathologic features and neo-adjuvant chemotherapy response.
    Arenas-Huertero FJ; Herrera-Goepfert R; Delgado-Chavez R; Zinser-Sierra JW; De la Garza-Salazar JG; Herrera-Gomez A; Perez-Cardenas E
    J Exp Clin Cancer Res; 1999 Sep; 18(3):279-84. PubMed ID: 10606169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas.
    Liu SY; Liu YC; Huang WT; Huang GC; Su HJ; Lin MH
    J Oral Pathol Med; 2007 Aug; 36(7):430-5. PubMed ID: 17617837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.